title: [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
abstract: To study insulino-mimetic effects of bis(alpha-furancarboxylato) oxovanadium (IV) (BFOV), a orally active antidiabetic vanadyl complex, on glucose uptake and lipogenesis in isolated rat adipocytes were determined by using 2-deoxy-D-[3H]-glucose and D-[3H]-glucose, respectively. Lipolysis was assayed by free fatty acids (FFA) released from isolated rat adipocytes treated with epinephrine. The results showed that BFOV, similar to insulin, concentration-dependently significantly enhanced the uptake of 2-deoxy-D-[3H]-glucose and the transformation from D-[3H]-glucose to lipid in isolated rat adipocytes, with the EC50 values of (0.31 +/- 0.08) mmol L(-1) and (0.49 +/- 0.12) mmol L(-1), respectively. Moreover, BFOV markedly inhibited FFA release from isolated rat adipocytes treated with epinephrine, and the IC50 value was (0.30 +/- 0.20) mmol L(-1). BFOV had insulino-mimetic effects such as enhancing glucose uptake and lipogenesis, as well as inhibiting lipolysis.
authors.affiliation: Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College, Kunming 650031, China.
authors.forename: Yan-Rong
authors.initials: YR
authors.lastname: Li
authors.forename: Li-Hui
authors.initials: LH
authors.lastname: Gao
authors.forename: Yan-Lin
authors.initials: YL
authors.lastname: Ma
authors.forename: Yan-Fen
authors.initials: YF
authors.lastname: Niu
authors.forename: Wei-Ping
authors.initials: WP
authors.lastname: Liu
authors.forename: Ling
authors.initials: L
authors.lastname: Li
mesh_terms: D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology; D050155:Lipogenesis / Q000187:drug effects; D008297:Male; D009942:Organometallic Compounds / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D009942:Organometallic Compounds; C512927:bis(alpha-furancarboxylato)oxovanadium(IV)